ConvaTec Group (LON:CTEC) Earns "Overweight" Rating from JPMorgan Chase & Co.

Key Points

• ConvaTec Group's stock has received an "overweight" rating from JPMorgan Chase & Co., reaffirming positive investor sentiment.
• The company has a consensus rating of "Buy" from five analysts, with an average target price of GBX 303.40 ($4.05).
• Recently, shares of ConvaTec Group traded down 4.2%, with a current price of GBX 234.20 ($3.13) and a market cap of £5.96 billion.

JPMorgan Chase & Co. reissued their overweight rating on shares of ConvaTec Group (LON:CTEC - Free Report) in a research report report published on Wednesday, MarketBeat.com reports.

Several other analysts also recently commented on the stock. Peel Hunt reissued an "add" rating and issued a GBX 280 ($3.72) target price on shares of ConvaTec Group in a research report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 315 ($4.18) target price on shares of ConvaTec Group in a research note on Thursday, July 3rd.

ConvaTec Group Price Performance

Shares of LON:CTEC traded down GBX 2.70 ($0.04) during trading on Wednesday, reaching GBX 230.70 ($3.06). The company had a trading volume of 10,209,894 shares, compared to its average volume of 14,010,055. The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The firm's fifty day moving average is GBX 270.11 and its 200 day moving average is GBX 259.23. ConvaTec Group has a twelve month low of GBX 211.80 ($2.81) and a twelve month high of GBX 311.20 ($4.13). The firm has a market capitalization of £5.87 billion, a PE ratio of 38.85, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.